The natural compound 2,3-BTD has diverse physiological effects in a range of organisms, including acting as a detoxifying product of liver alcohol metabolism in humans and ameliorating endotoxin-induced acute lung injury in rats. In this study, we reveal that 2,3-BTD enhances NK cell cytotoxic activity in human pNK cells and NK92 cells. Treatment of NK cells with 2,3-BTD increased perforin expression in a dose-dependent manner. This was accompanied by elevated JNK and ERK1/2 MAPK activities and enhanced expression of NKG2D/NCRs, upstream signaling molecules of the MAPK pathways. The 2,3-BTD effect was inhibited by pretreatment with inhibitors of JNK (SP) or ERK1/2 (PD) or by depleting NKG2D/NCRs or JNK1 or ERK2 with siRNA. These results indicate that 2,3-BTD activates NK cell cytotoxicity by NKG2D/NCR pathways and represent the first report of the 2,3-BTD effect on activation of innate immunity cells. J. Leukoc. Biol. 92: 000 -000; 2012.
Introduction
The low molecular-weight compound 2,3-BTD, which is widely synthesized in humans [1] , yeast [2] , and bacteria [3] , is involved in a variety of biological activities. These include homeostasis of environmental pH when bacteria grow to high cell density [4] , stimulation of bacterial biofilm formation [5] , enhancement of plant growth and systemic resistance against bacteria [6] , tolerance to drought in Arabidopsis thaliana [7] , activity as a beetle pheromone [8] , and potent CNS-depressant effect in rats [9] .
This remarkable functional repertoire suggests that 2,3-BTD may act as a signaling molecule in a wide variety of species [6, 8] . Recently, we reported that 2,3-BTD ameliorates endotoxin-induced acute lung injury in rats [10] . We also characterized the effect of RSV on NK cell NKG2D/NCR signaling and cytotoxic activity [11] . However, whether 2,3-BTD plays a role in modulating immune activity via regulation of NK cell cytotoxicity activity remains to be characterized.
The NK cells are important for early host defense against infection and tumors [12] [13] [14] . NK cells are with the capability of granule exocytosis by releasing granule proteins, such as perforin, granzymes, and granulysin [15] . The NK cell cytotoxic activity is controlled by coordinated signals generated from the ligation of inhibitory and activating receptors [16] . The major activating receptors are the NCRs, comprising constitutively expressed NKp46 [17] and NKp30 [18] , and the induced NKp44 [19] . Moreover, the NKG2D receptor, which is also identified in human T cells [20] , also involves activating NK cell cytotoxicity [21] . The ligation of the activating receptors lead to activation of a cascade of intracellular signaling, resulting in polarization and exocytosis of granules to lyse the TS [16, 22] . In NK cells, ERK, JNK, and p38 are intermediates of the important signaling MAPK pathways that regulate granule polarization, which is mediated by reorientation of the microtubule organizing center to the synapse [23, 24] .
In the present study, we show that the cytotoxic activity of the pNK cells and NK92 cells with 2,3-BTD pretreatment is enhanced significantly compared with that of the untreated groups. Subsequently, we investigate the potential signaling pathways involved in 2,3-BTD-stimulated NK cell cytotoxicity. Our results indicate that the effect is mediated through activation of NCR/NKG2D pathways, which, in turn, leads to increased cytotoxic activity.
MATERIALS AND METHODS

Cell isolation and culture
The human NK cell line NK92 was derived from a non-Hodgkin's lymphoma (ATCC CRL-2407) [25] . NK92 cells were maintained in culture with 100 IU/ml IL-2 (PeproTech, Rocky Hill, NJ, USA). pNK cells were collected from healthy individuals using the protocol by Favier et al. [26] . Briefly, pNK cells were isolated from peripheral blood using the EasySep NK cell depletion kit, as recommended by the manufacturer (Stem Cells, Grenoble, France). The purity of pNK cells was verified systematically by flow cytometry based on CD16, CD56, and CD3 expression. pNK cells were used only when cell preparations contained Ͼ80% CD16 ϩ
CD56
ϩ and were devoid of CD3 ϩ cells. pNK cells were activated by adding 200 UI/ml IL-2 (PeproTech, Rocky Hill, NJ, USA) to the culture medium for 36 -48 h. All cell lines were cultured in ␣MEM (Gibco, Grand Island, NY, USA), containing 2 mM l-glutamine, 1.5 g/L sodium bicarbonate, 12.5% horse serum, and 100 U/ml IL-2. The K562 cell line (ATCC) was maintained in RPMI-1640 medium containing 10% FBS.
Chemical reagents and media
␣MEM without ribonucleosides and deoxyribonucleosides and RPMI-1640 medium without phenol red, horse serum, and FBS were from Invitrogen (Carlsbad, CA, USA). Inositol, 2-ME, folic acid, glutamine, JNK inhibitor SP, ERK1/2 inhibitor PD, and p38 MAPK blocker SB were purchased from Sigma-Aldrich (St. Louis, MO, USA). Inhibitors were stored in DMSO at Ϫ20°C. 2,3-BTD (Fluka, Sigma-Aldrich) was dissolved in saline and PBS for further assays.
Antibodies
Human rIL-2 was purchased from PeproTech (London, UK). Mouse polyclonal antibodies against perforin were from Abnova (Taipei, Taiwan); mouse anti-human NKG2D, NKp30, NKp44, and NKp46 antibodies were from R&D Systems (Minneapolis, MN, USA); rabbit polyclonal anti-ERK, JNK, p38, antiphospho-ERK (Thr202/Tyr204), antiphospho-JNK (Thr183/ Tyr185), and antiphospho-p38 (Thr180/Tyr182) were from Cell Signaling Technology (St. Quentin en Yvelines, France), and mouse anti-GAPDH mAb was from Chemicon International (Temecula, CA, USA).
Flow cytometric analysis of NKG2D/NCRs
The cells (1ϫ10 6 cells/well) were collected by centrifugation at 500 g at 4°C, washed once with PBS, and resuspended in 500 ml PBS. The cells were then incubated with 2% BSA to block nonspecific antigens for 30 min, followed by anti-human NKG2D NKp30 and NKp46 antibodies (R&D Systems) and anti-human NKp44 (Becton Dickinson, San Jose, CA, USA) for another 30 min on ice. The binding cells were washed with PBS twice. Finally, the samples were analyzed by flow cytometry using a FACScan flow cytometer (Becton Dickinson).
siRNA transfection
The siRNAs against human p38 (sc-29433), JNK1 (sc-29380), ERK2 (sc-35335), NKG2D (sc-42948), NKp44 (sc-72170), NKp46 (sc-63344), and NKp30 (sc-42950) and a control siRNA (sc-37007) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Transfection of siRNAs into NK92 cells was performed according to instructions (Amaxa, Gaithersburg, MD, USA).
Cytotoxicity assays
Stress-induced cytotoxicity was evaluated by a CytoTox 96 nonradioactive cytotoxicity assay [27] (Promega, Madison, WI, USA), based on the colorimetric measurement of LDH, a stable cytosolic enzyme released upon cell lysis. NK ES (5ϫ10 4 , 2.5ϫ10 4 , and 5ϫ10 3 cells/well in U-bottom 96-microwell plates; Corning, Corning, NY, USA) were pretreated with or without JNK or ERK1/2 inhibitor for 30 min, followed by treatment with 2,3-BTD for 16 h. Cells were then washed and resuspended in RPMI 1640 (without phenol red), supplemented with 2% FBS. To these were added a fixed number of K562 TS (5ϫ10 3 / well) at the E:T ratio of 1:1, 5:1, or 10:1. The microplates were then spun for 4 min at 250 g to settle the cell mixtures before incubation for 4 h at 37°C in 5% CO 2 . After this coincubation, supernatant (50 l) was collected from each well, added to 50 l reconstituted substrate mix, and incubated for 30 min in the dark at room temperature. The enzymatic reaction was stopped by Stop Solution (50 l), and the absorbance at 490 nm was measured. TM was determined by lysing TS with 10 l lysis solution. Spontaneous release by the TS or ES was determined following incubation alone at the respective cell concentrations. Results were expressed as percentage cytotoxicity, calculated as [(experimentalϪESϪTS)/(TMϪTS)] ϫ 100.
RNA isolation and real-time PCR
mRNA was isolated from pNK cells using the Qiagen RNeasy kit (Qiagen, Valencia, CA, USA), following the manufacturer's instructions, and total RNA was converted into cDNA by standard reverse transcription with the Taqman RT kit (Applied Biosystems, Foster City, CA, USA). qPCR was performed with 1/50 of the cDNA preparation in an Mx3000P (Stratagene, La Jolla, CA, USA) in a 25-ml final volume with Brilliant QPCR Master Mix (Stratagene). The real-time PCR included an initial denaturation at 95°C for 10 min, followed by 40 cycles of 95°C for 30 s, 55°C for 1 min, and 72°C for 1 min and one cycle of 95°C for 1 min, 55°C for 30 s, and 95°C for 30 s.
Western blot analysis of proteins
NK cells (10 6 /flask) were plated for 24 h in IL-2-free medium containing 12.5% horse serum and 12.5% FBS. Cells were then treated with the indicated inhibitors for 30 min, followed by a specific dose of 2,3-BTD for 16 h. Washed cells were lysed in mammalian protein extraction reagent (Pierce Chemical, Thermo Scientific, Rockford, IL, USA). Total lysate protein samples (40 g/ lane) were fractionated on a 10% SDS polyacrylamide gel and blotted onto PVDF membranes (Immobilon-P, Millipore, Billerica, MA, USA). Membranes were blocked with 5% nonfat milk for 1 h at room temperature in TBST (Tris 10 mM, NaCl 150 mM, pH 7.6, containing 0.1% Tween 20) and probed with primary antibodies (1:1000 for antiperforin, anti-NKG2D, anti-NKp30, antiNKp44, anti-NKp46, anti-ERK, anti-JNK, anti-p38, antiphospho-ERK, antiphospho-JNK, and antiphospho-p38 and 1:10,000 for anti-GAPDH) overnight at 4°C. Membranes were then incubated with appropriate HRP-conjugated secondary antibodies (1:5000). Immunoreactive protein bands were developed by ECL (Amersham Pharmacia Biotech, Germany).
Data analysis
Statistical analysis was performed using ANOVA (SPSS 12.0 software, SPSS, Chicago, IL, USA) with a correction for multiple comparisons. A difference between results of two assay conditions that gave a P value Ͻ 0.05 was considered to be significant.
RESULTS
2,3-BTD increases NK92 cell and human pNK cell cytotoxicity
Whether 2,3-BTD has any effect on modulation of NK cell immune activity was first addressed. We treated NK92 cells with 2,3-BTD at different concentrations, followed by coincubation with K562 cells at an E:T ratio of 1, 5, and 10, respectively. As shown in Fig. 1A , the cytotoxic activity of NK92 cells was stimulated by 2,3-BTD in a dose-dependent manner. At a concentration of 10 M, the activity was increased by 150% compared with that of the untreated cells at the same E:T ratio of 10. Subsequently, pNK cells were pretreated with or without desired doses of 2,3-BTD, followed by measuring NK cell cytotoxic activity. The cytotoxic activity of 2,3-BTD-treated pNK cells was enhanced dose-dependently compared with that of the nontreated groups ( Fig. 1B; PϽ0.01 ). These results indicate that 2,3-BTD treatment increases NK cell cytotoxicity activity.
2,3-BTD enhances perforin expression in NK cells
The possible effect of 2,3-BTD on increasing NK cell cytotoxic activity might be through enhancing perforin and/or granulysin expression. To determine whether this may be possible, cells were treated with 2,3-BTD at increasing concentrations for 2 h, and the perforin and granulysin mRNA levels were then quantified by real-time PCR. As shown in Fig. 1C , the abundance of perforin mRNA was increased by 2,3-BTD treatment in a dosedependent manner. At a 2,3-BTD concentration of 10 M, the perforin mRNA levels were increased by 6.8-fold compared with that of the untreated cells. By contrast, granulysin mRNA expression was not obviously affected. Furthermore, Western blot analysis indicated that production of perforin, but not granulysin, was increased by 2,3-BTD treatment in a dose-dependent manner (Fig. 1D) . At 10 M, the stimulation by 2,3-BTD was up to sevenfold higher. Intriguingly, the expression of granzyme B was also increased by 2,3-BTD treatment in a dose-dependent manner in pNK cells (Supplemental Fig. 1 ). 2,3-BTD enhanced the expression and polarization of perforin when the stained pNK cells were detected by fluorescence microscopy (Supplemental Fig. 2) .
Briefly, 2,3-BTD enhances perforin expression and cytotoxicity in NK cells.
2,3-BTD activates perforin expression through NKG2D/NCRs
The potential effect of 2,3-BTD on mRNA and protein level expression of NKG2D and NCRs, which act upstream of perforin, was next evaluated. As shown in Fig. 2A , the NKG2D, NKp44, and NKp46 receptor mRNA levels were clearly enhanced by 2,3-BTD in a dose-dependent manner. Concomitantly, protein production of the three receptors was also enhanced after 2,3-BTD treatment, and an increase of 4.9-fold in NKp46 and 12.7-fold in NKp44 was most significant (Fig. 2B) . In comparison, NKp30 expression was not affected by 2,3-BTD. To see whether NKG2D, NKp30, NKp44, and NKp46 were involved in 2,3-BTD activation of perforin production, the protein levels of these receptors were knocked down by RNAi, followed by measurement of perforin production. As shown in Fig. 2C-F , the NKG2D, NKp30, NKp44, and NKp46 protein levels were reduced significantly by RNAi treatment as compared with the scramble control groups. Simultaneously, 2,3-BTD-stimulated expression of perforin was attenuated significantly by transfection with the siRNA. Together, 2,3-BTD en- hances perforin expression via increased expression of NKG2D, NKp44, and NKp46.
2,3-BTD stimulates NKG2D/NCR-mediated ERK1/2 and JNK MAPK pathways
MAPK signaling is implicated in NK cell-mediated tumor cell lysis [28, 29] . In addition, inhibition of JNK and/or ERK1/2 signaling interferes with NKG2D-mediated cytotoxicity [23] .
To examine whether 2,3-BTD affects ERK1/2, JNK, and p38 activities, the NK cells were treated with different doses of 2,3-BTD, and the levels of phospho-ERK (Thr202/Tyr204), phospho-JNK (Thr183/Tyr185), and phospho-p38 (Thr180/ Tyr182) were examined by Western blot analysis. As shown in Fig. 3A, 2,3 -BTD stimulated the phosphorylation of ERK1/2 and JNK in a dose-dependent manner, whereas it exerted little or no effect on p38 phosphorylation. To examine which MAPK signaling pathway is involved in the 2,3-BTD (10 M) NKG2D/NCR-mediated cytolytic activity, specific inhibitors to individual MAPKs were used. Inhibition of JNK activity by SP (10 M) and ERK1/2 activity by PD (10 M) reduced cytotoxicity by ϳ57% and ϳ23%, respectively. In contrast, inhibition of p38 by SB (10 M) had little effect (6%; Fig. 3B ). We also observed that there was no difference in cytotoxicity after ERK and JNK inhibitor treatment for 30 min or 16 h (Supplemental Fig. 3 ). In brief, 2,3-BTD activates NKG2D/NCR-dependent ERK1/2 and JNK MAPK activities. 
ERK activity involves 2,3-BTD-stimulated NK cell perforin production and cytotoxicity
To ascertain whether ERK1/2 activation plays a role in perforin-mediated cytotoxicity in 2,3-BTD-treated NK cells, the cells were treated with increasing doses of the ERK1/2 inhibitor PD for 30 min before 2,3-BTD treatment. As shown in Fig. 4A , PD at 5-20 M significantly attenuated 2,3-BTD (10 M)-stimulated ERK1/2 kinase activity. Furthermore, the dose-dependent activation of ERK1/2 phosphorylation and perforin production by 2,3-BTD was attenuated concurrently by PD at 10 M (Fig. 4B) . We next evaluated whether 2,3-BTD-activated cytotoxic activity could be reduced by inhibition of ERK activity. NK cells were treated with/without 10 M PD and/or increasing 2,3-BTD concentrations, as described, and then mixed with K562 cells at an E:T ratio of 10:1. As shown in Fig.  4C , 2,3-BTD treatment resulted in a significant increase of the cytotoxic activity compared with that of the untreated cells. As expected, pretreatment with PD significantly attenuated the cytotoxic activity of the NK cells activated by 2,3-BTD stimulation. To further characterize the ERK involvement, NK cells were transfected with siRNA against ERK2 to determine whether perforin production stimulated by 2,3-BTD treatment was affected. Figure 4D shows that transfection of ERK2 siRNA markedly reduced the production of ERK2 and perforin protein after treatment of NK cells with 10 M 2,3-BTD. Moreover, transfection of NK92 cells with ERK2 siRNA markedly reduced cytotoxicity against K562 cells (Fig. 4E) . In contrast, knockdown of p38 did not exhibit any significant effects (data not shown). In conclusion, ERK activity mediated the 2,3-BTDstimulated perforin production and cytotoxicity in NK cells.
JNK activity involves 2,3-BTD-stimulated perforin production and cytotoxicity
The JNK pathway also involves regulation of perforin expression and cytotoxic activity of NK cells [23] . Whether the JNK inhibitor SP attenuates 2,3-BTD-dependent JNK activation and perforin production was studied next. NK cells were incubated with increasing concentrations of SP for 30 min, followed by 2,3-BTD treatment. As shown in Fig. 5A , the JNK inhibitor reduced 2,3-BTD-stimulated JNK phosphorylation in a dose-dependent manner. Concomitant with reduced JNK pathway activity, 2,3-BTD stimulation of perforin production was also attenuated by SP at 10 M (Fig. 5B) . In a second series of experiments, NK cells were treated with or without SP for 30 min, followed by increasing doses of 2,3-BTD treatment for another 30 min. The cytotoxic activity was then assayed at an E:T ratio of 10. As shown in Fig. 5C, 2,3 -BTD exerted significant stimulation of the cytotoxic activity against K562 cells. Pretreatment with SP also significantly attenuated the cytotoxic activity of the NK cells, irrespective of 2,3-BTD stimulation. Furthermore, 2,3-BTD-dependent JNK phosphorylation and perforin production were attenuated significantly by transfection with JNK1 siRNA (Fig. 5D) . Moreover, transfection with JNK1 siRNA also led to a significant decline of cytotoxicity (Fig. 5E) . Briefly, JNK plays a role in 2,3-BTD-stimulated perforin production and cytotoxicity in NK cells.
Increased NK cell cytotoxicity by 2,3-BTD stimulation is not target-cell-specific
To evaluate whether the increased NK cell cytotoxic activity as a result of 2,3-BTD treatment is specific for the TS, NK cells were treated with increasing concentrations of 2,3-BTD, followed by coculture with HepG2 or A549 cells. Figure 6A and B showed that NK cell cytotoxic activity against HepG2 or A549 cells is stimulated by 2,3-BTD in a dose-dependent manner at the E:T ratio of 10. We used Western blot analysis to determine whether the common NKG2D ligand-MICA/B is expressed on the three TS lines [30] . The results showed that MICA/B proteins are expressed by all three tumor cell lines tested (Fig. 6C ).
DISCUSSION
In this study, we show that 2,3-BTD stimulates NK cell cytotoxic activity. The activation appears to be a result of activation of the major NK cell-activating receptors NKG2D, NKp44, and NKp46, leading to the activation of the ERK1/2 and JNK pathways, which, in turn, mediate the up-regulation of perforin production and perforin-mediated cytotoxicity. Although 2,3-BTD plays multiple roles in regulation of physiological functions in bacteria, plants, beetles, and rats, to our knowledge, this is the first report about the effect of 2,3-BTD on activation of innate immune cells. The enhanced NK cytotoxic activity is effective, not only against the K562 but also A549 and HepG2 cell lines, indicating a general ability of 2,3-BTD to activate NK cells against tumor cells. Expression of another cytotoxic protein, granulysin, was not affected by 2,3-BTD treatment. This phenomenon suggests that expression of granulysin might be under control by a different pathway than perforin. Alternatively, as granulysin is expressed 3-5 days after NK cell activation [31] , a longer time might be needed for effects of 2,3-BTD on granulysin expression. The mechanism of 2,3-BTD effect on activation of NK cells remains not fully understood. 2,3-BTD is reported to act as a signaling molecule in a wide variety of species. It acts as a male pheromone emitted by the Dynast beetle, Scapanes australis [8] . Furthermore, studies with Arabidopsis mutant lines indicated that 2,3-BTD induced systemic drought tolerance through the salicylic, ethylene, and jasmonic acid-signaling pathways [7] . Moreover, a role for cytokine-signaling pathways in growth promotion of Arabidopsis by bacterial 2,3-BTD was also reported [32] . In humans, 2,3-BTD, which is metabolized from ethanol, is present in Ͻ5% of normal individuals with serum concentrations Ͼ5 M [1] . The blood concentration of 2,3-BTD in nonalcoholics was 0.5-0.8 M. By contrast, 2 h after alcohol ingestion, blood levels had risen the 2,3-BTD concentration to 1.2 M [33] . Results from this study suggested that 2,3-BTD involves control of signaling pathways, leading to NK cell activation. As expression of perforin is also under the control of NF-B in NK cells [34] , it is likely that 2,3-BTD treatment may enhance NF-B translocation in NK cells. In comparison, results from our previous in vivo study showed that pretreatment of rat lungs with 2,3-BTD (10 mole kg Ϫ1 ) ameliorates LPS-induced acute pneumonia symptoms [10] . 2,3-BTD appears to inhibit NF-B translocation through inhibition of IB␣ phosphorylation in rat lung tissue, resulting in reduced expression levels of TNF-␣, IL-1␤, and IL-6 and a decrease in acute inflammation [10] . It is interesting that a small molecule such as 2,3-BTD can have such distinct and diverse biological effects. One possible explanation is that 2,3-BTD may resemble or mimic an endogenous signaling molecule. Alternatively, after metabolism into different metabolic intermediates, the effects of 2,3-BTD may vary depending on the timing, doses, and experimental systems to which it is added. Another possibility is it exerts its effects through a series of fortuitous interactions with other molecules once inside a cell, ass we have also observed that Fas ligand or TRAIL expression was up-regulated in pNK cells with 2,3-BTD 10 M treatment (Supplemental Fig. 4 ). All of these are important issues needed to be addressed. Based on these reports, 2,3-BTD thus seems to have an immune-modulatory effect. Treatment of 2,3-BTD may not only reduce inflammation of lung tissue cells, but it can also activate resting NK cells. Hence, 2,3-BTD may affect different signaling pathways in different TS.
An important future research direction will be the identification of cell-signaling molecules targeted by 2,3-BTD. The structure of 2,3-BTD is rather simple, comprising four carbon atoms and two hydroxyl (ϪOH) groups. Intriguingly, the 2,3-BTD structure is different from most compounds or hormones identified. Whether 2,3-BTD interacts directly with NKG2D or NCRs remains to be determined. With the use of the human cell line NK92 as the study model, we have observed consistently that knockdown of each of the activating receptors leads to decreased perforin production. We also observed that in the case of 2,3-BTD treatment, the receptor redundancy did not appear to mask the effect of the knockdowns. They were reproducible experimental results. Furthermore, besides the possibility of interacting with extracellular receptors, it is expected that 2,3-BTD may diffuse into NK cells and interact with intracellular signaling mediators. We have reported previously that RSV, a natural polyphenolic compound purified from grape seeds, shows a similar ability to activate NK cells [11] . An increase in the expression of NKG2D, activity of MAPKs, and perforin production was also observed when NK cells were treated with RSV. Compared with RSV, which enhances only NKG2D production, 2,3-BTD enhances NKG2D and NCR expression. Thus, although 2,3-BTD and RSV activate NK cell cytotoxicity, the underlying activation mechanisms might vary, which is worthy of further study.
Although the role of 2,3-BTD in diseases remains unclarified, the production of 2,3-BTD is associated closely with some liverrelated diseases. The 2,3-BTD synthesis is increased in severely alcoholic humans closely related to hepatocelular carcinoma [1] . Besides, in patients whose livers were chronically infected with Schistosomiasis japonica, production of 2,3-BTD was also increased in the patients' sera [35] . Whether 2,3-BTD shows any effect on amelioration of liver damage is to be studied. It is possible that increased 2,3-BTD production may activate NK cells in response to stresses against liver. This may lead to enhanced innate immunity and result in clearance of damaged liver cells. In conclusion, 2,3-BTD activates NK cell NKG2D/NCR signaling pathways and enhances NK cell cytotoxicity. Thus, 2,3-BTD should be considered as a compound for activating NK cell activity.
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